For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $15.19 in the prior trading day, Integra Lifesciences Holdings Corp (NASDAQ: IART) closed at $15.67, up 3.16%. In other words, the price has increased by $3.16 from its previous closing price. On the day, 0.73 million shares were traded. IART stock price reached its highest trading level at $15.7 during the session, while it also had its lowest trading level at $15.11.
Ratios:
Our goal is to gain a better understanding of IART by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.47. For the most recent quarter (mrq), Quick Ratio is recorded 0.71 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 1.28 whereas as Long-Term Debt/Eq ratio is at 0.88.
On December 02, 2024, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 03 ’24 when Schwartz Eric sold 4,070 shares for $24.59 per share. The transaction valued at 100,102 led to the insider holds 59,511 shares of the business.
Schwartz Eric bought 4,070 shares of IART for $100,102 on Dec 03 ’24. On Dec 02 ’24, another insider, McBreen Michael J., who serves as the EVP & President, CSS of the company, sold 1,700 shares for $24.16 each. As a result, the insider received 41,064 and left with 56,182 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IART now has a Market Capitalization of 1222866560 and an Enterprise Value of 2922845440. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.75 while its Price-to-Book (P/B) ratio in mrq is 0.78. Its current Enterprise Value per Revenue stands at 1.815 whereas that against EBITDA is 9.053.
Stock Price History:
The Beta on a monthly basis for IART is 1.36, which has changed by -0.466644 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, IART has reached a high of $32.66, while it has fallen to a 52-week low of $14.45. The 50-Day Moving Average of the stock is -26.77%, while the 200-Day Moving Average is calculated to be -29.95%.
Shares Statistics:
The stock has traded on average 693.58K shares per day over the past 3-months and 798040 shares per day over the last 10 days, according to various share statistics. A total of 77.17M shares are outstanding, with a floating share count of 66.10M. Insiders hold about 14.38% of the company’s shares, while institutions hold 92.67% stake in the company. Shares short for IART as of 1743379200 were 3308682 with a Short Ratio of 4.77, compared to 1740700800 on 3909373. Therefore, it implies a Short% of Shares Outstanding of 3308682 and a Short% of Float of 7.000000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
